3679 — ZIGExN Co., Ltd.

ZIGExN (3679, TSE Prime) — deep-value analysis

Executive summary

ZIGExN is a Japanese roll-up of vertical matching platforms: 40+ services bought or built around recruiting niches (hair/wellness, pharmacy, manufacturing, construction, transportation, real estate, work-related travel) and lifestyle services (rentals, renovations, energy comparison, hotel booking for agencies). The economic model is simple: the company buys traffic (SEO plus paid media), converts it into qualified leads and sells it to client companies, either as a listing subscription (掲載課金) or — increasingly — as a success fee on hiring (成果課金, typically 30… of annual salary). In FY2026/3 it generated revenue of … (…), EBITDA 7,592 mil (…), operating profit 5,913 mil (…) and profit attributable to shareholders 4,157 mil (…), with 1,350 employees and 23,335 active corporate clients.

The investment thesis has three legs. First: the price. At …, market cap is …, i.e. 10.8× TTM profit, 10.4× the FY2027 guidance (EPS 44.09), 4.9× EBITDA on enterprise value and an 8.3% yield on rigorously calculated free cash flow to shareholders (see the FCF bridge). The company has entered its own cheapest decile: the P/E multiple at fiscal-year close fell 17.3× (FY2023) → 17.0× → 11.4× → 9.8× (FY2026), while EPS rose from 27.85 to 41.66. Five-year total shareholder return (index from the 有価証券報告書, March 2021 base = 100) is 101.7 versus 202.2 for TOPIX with dividends — the stock stood still for five years while profit nearly doubled. Second: the balance sheet. Cash 12,579 mil, interest-bearing debt 4,318 mil, net cash position 8,261 mil (18% of market cap), no restrictive financial covenants on loans (有価証券報告書, note 4 on financial liabilities), average debt cost ~1.0%, finance-cost coverage above 150×. Third: alignment. Founder-CEO Hirao Takeshi controls 54.63% of shares outstanding (Joygen 49.31% + direct 5.32%), total remuneration of the four internal directors is … a year, and share options are bought with the recipients’ own money at fair value, not granted.

The counter-thesis is just as concrete, which is why the verdict isn’t “cheap, so buy.” Operating margin has fallen three years running: 23.2% (FY2024) → 22.2% → 20.2% (FY2026) → 20.5% in Q1 FY2027, and in the engine segment Vertical HR the margin before common-cost allocation fell from 30.3% (Q1 FY2026) to 25.3% (Q1 FY2027). The cause is structural, not cyclical: the shift from listings (high, scalable margin) to placement brokerage (human consultants, lower margin). Second: … of goodwill on 22,306 mil equity — 34% of assets. The company has been through this before: in FY2021/3 goodwill fell from 9,428 to 6,655 mil (Apple World 2,225 → 497, Sanko Ad 2,012 → 432) and operating profit turned into a … mil loss, with EBITDA still positive at 3,808. Third: Life Service, almost half of guided FY2027 revenue (18,000 of 33,500), fell 2% in Q1 and has been flat for three years.

Estimated value, from five triangulated models: range 335–…/share, median …, i.e. a median margin of safety of … versus …. The Monte Carlo simulation across 20,000 scenarios gives a median intrinsic value of … (… MOS), with an …% probability of undervaluation, but also a P10 of …. The no-growth earning power value (EPV Greenwald) is …, i.e. …: at today’s price you’re paying almost exactly for the current earning power, and everything above that depends on the execution of the Vertical HR pivot.

Verdict: BUY, moderate (not concentrated) position. The price gives real downside protection — net cash, … flow yield, an owner-operator with 55% of capital, the multiple at a six-year own low — but the upside is conditional on an operational thesis that hasn’t yet been validated: that margin stabilizes once consultant cohorts mature and that AI delivers the productivity promised in the three-year plan. This is an accumulation position, with a review trigger at the Q2 FY2027 report (November 2026): Vertical HR margin and receivables turnover are the two figures that decide the thesis.